SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001354488-13-006673
Filing Date
2013-11-29
Accepted
2013-11-29 07:09:13
Documents
3
Period of Report
2013-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tbuff_8ka.htm 8-K/A 24311
2 PRESS RELEASE DATED NOVEMEBER 14, 2013 tbuff_ex991.htm EX-99.1 274594
3 tribute.jpg GRAPHIC 5105
  Complete submission text file 0001354488-13-006673.txt   307356
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 131249151
SIC: 2834 Pharmaceutical Preparations